Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Jewish General Hospital
Sponsor:
Collaborators:
Quebec Clinical Research Organization in Cancer
Genome Quebec
Information provided by (Responsible Party):
Mark Basik, Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT01276899
First received: January 12, 2011
Last updated: November 28, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given